Synthesis, characterization, and pharmacological evaluation of 1-[2-(6-nitro-4-oxo-2-phenyl-4H-quinazolin-3-yl)-ethyl]-3-phenyl ureas

Medicinal Chemistry Research

Volumn 22, Issue 1, 2013, Pages 225-233

  Rana, Aniruddhasinh M ^a   Desai, Kishor R ^b   Jauhari, Smita ^a  

^a SARDAR VALLABHBHAI NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^b C G Bhakta Institute of Biotechnology   (India)

Author keywords

Antimicrobial activity; Phenyl isocyanates; Quinazolin 4(3H) one

Indexed keywords

1 (2 CHLORO 5 TRIFLUOROMETHYL PHENYL) 3 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] UREA; 1 (2 CHLORO PHENYL) 3 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] UREA; 1 (3,5 BIS TRIFLUOROMETHYL PHENYL) 3 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] UREA; 1 (4 CHLORO PHENYL) 3 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] UREA; 1 (4 METHYL CYCLOHEXYL) 3 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] UREA; 1 (4 METHYLSULFANYL PHENYL) 3 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] UREA; 1 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] 3 (4 TRIFLUOROMETHYL PHENYL) UREA; 1 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] 3 O TOLYL UREA; 1 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] 3 P TOLYL UREA; 1 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] 3 PHENYL UREA; 1 CYCLOHEXYL 3 [2 (6 NITRO 4 OXO 2 PHENYL 4H QUINAZOLIN 3 YL) ETHYL] UREA; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; FLUCONAZOLE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; BROTH DILUTION; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DISK DIFFUSION; DRUG ANALYSIS; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ESCHERICHIA COLI; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 84872031959     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0004-3     Document Type: Article

References (18)

1. Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, Abdel-Aziz AM, El-Azab AS, Al-Khamees HA, El-Subbagh HI (2009) Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Eur J Med Chem 44:2379-2391
2. Al-Rashood ST, Aboldahab IA, Nagi MN, Abouzeid LA, Abelaziz AM (2006) Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg Med Chem 14:8608-8621
3. Ammar YA, Mohamed YA, El-Sharief AM, El-Gaby MS, Abbas SY (2011) Synthesis of some biologically active 4(3H)-quinazolinones derived from 2,3-pyridine dicarboxylic anhydride. Chem Sci J 15:1-7
4. Casenghi M, Cole S, Nathan C (2004) New approaches to filling the gap in tuberculosis drug discovery. Nature 431:899-902
5. Collins CH, Lyne PM (1970) Microbiological methods. Butterworth, London
6. Frezza M, Castang S, Estephane J, Soulere L, Deshayes C, Nasser W, Reverchon S, Doutheau A (2006) Synthesis and biological evaluation of homoserine lactone derived ureas as antagonists of bacterial quorum sensing. Bioorg Med Chem 14:4781-4791
7. Kumar A, Rajput CS, Bhati SK (2007) Synthesis of 3-[4′-(p- chlorophenyl)-thiazol-2′-yl]-2-[(substituted azetidinone/thiazolidinone)- aminomethyl]-6-bromoquinazolin-4-ones as anti-inflammatory agent. Bioorg Med Chem 15:3089
8. Laddha SS, Wadodkar SG, Meghal SK (2006) Studies on some biologically active substituted 4(3H)-quinazolinones. Synthesis, characterization and anti-inflammatory-antimicrobial activity of 6,8-disubstituted 2-phenyl-3-[substituted-benzothiazol-2-yl]-4(3H)-quinazolinones. ARKIVOK 11:1-20
9. Mullen GB, Decory TR, Mitchell JT, Allen SD, Kinsolving CR, Georgiev VS (1988) Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H- imidazol-1-ylmethyl)-2-alkylisoxazolidine derivatives. J Med Chem 31:2008-2014
10. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken R (1995) Manual of clinical microbiology. American Society for Microbiology, Washington, DC, pp 1342-1349
11. Pandey VK, Bajpai SK (2004) Thiadiazolyl quinaazolones as potential antiviral and antihypertensive agents. Indian J Chem 43B:180-183
12. Pereira MD, Chevrot R, Rosenfeld E, Thiery V, Besson TJ (2007) Synthesis and evaluation of the antimicrobial activity of novel quinazolinones. J Enzyme Inhib Med Chem 22:577
13. Raghavendra NM, Thampi P, Gurubasavarajaswamy PM, Sriram D (2007) Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones. Arch Pharm 340:635
14. Sharma P, Ashok K, Prerna K, Jitendra S, Kaushik MP (2011) QSAR modeling of synthesized 3-(1,3-benzothiazol-2-yl) 2-phenylquinazolin-4(3H)-ones as potent antibacterial agents. Med Chem Res. doi: 10.1007/s00044-011-9626-0
15. Sielecki IM, Johnson TL, Liu J, Muckelbauer JK, Graftstrom RH, Cox S, Boylan J, Burton CR, Chen H, Smallwood A, Chang C, Boisclair M, Benfield PA, Trainor GL, Seitz SP (2001) Quinazolines as cyclin dependent kinase inhibitors. Bioorg Med Chem Lett 11:1157
16. Silverstein RM, Webster FX (1997) Spectrometric identification of organic compounds, 6th edn. Wiley, New York, pp 79-223
17. Tiwari AK, Mishra AK, Bajpai A, Mishra P, Sharma RK, Pandey VK, Singh VK (2006) Synthesis and pharmacological study of novel pyrido-quinazolone analogues as anti-fungal, antibacterial, and anticancer agents. Bioorg Med Chem Lett 16:4581-4585
18. Wood ER, Truesdale AT, McDonald OB, Yuan D, Hassel A, Dickerson SH, Ellis B, Pennisi C, Horne E, Lackey K, Alligood KJ, Rusnak DW, Gilmer TM, Schewchuki L (2004) A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Res 64:6652-6659